anti-Clostridium perfringens toxin mAbs (Mapp/UAZ/UC Davis)

N/A

Report date: 2025/01/26 18:47:24

Base Information

Drug Nameanti-Clostridium perfringens toxin mAbs (Mapp/UAZ/UC Davis)
Drug Alias Nameanti-Clostridium perfringens epsilon toxin mAbs (Mapp biopharmaceutical/University of Arizona/University of California)anti-Clostridium perfringens epsilon toxin monoclonal antibodies (Mapp biopharmaceutical/University of Arizona/University of California)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsClostridium perfringens infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMapp Biopharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaMapp Biopharmaceutical IncThe University Of Arizona
Inactive CompaniesN/A
Active IndicationsClostridium perfringens infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A